brivudine and Glioma
brivudine has been researched along with Glioma* in 2 studies
Other Studies
2 other study(ies) available for brivudine and Glioma
Article | Year |
---|---|
Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice.
Human glioma cell lines 8-MG-BA and 42-MG-BA were infected with retrovirus vector containing the herpes simplex virus thymidine kinase (HSVtk) gene. The effect of acyclovir (ACV), ganciclovir (GCV), and bromovinyldeoxyuridine (BVDU) on both, parental and HSVtk expressing glioma cells was studied in vitro. BVDU displayed the most potent cytotoxic properties in HSVtk-containing cells, however bystander killing of nontransduced parental cells in a mixture with HSVtk-containing cells was less potent, than observed for ACV or GCV. Taking into account the cytotoxic effect of different prodrugs used, as well as their ability to kill nontransduced bystander cells, ganciclovir was shown to be the most effective. Therefore the effect of GCV treatment on 8-MG-BA xenografts inoculated with PA-317JH5cl13 virus producer cells was further studied on nude mice. Topics: Acyclovir; Animals; Antiviral Agents; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Ganciclovir; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Mice, Nude; Models, Chemical; Neoplasm Transplantation; Thymidine Kinase; Time Factors; Tumor Cells, Cultured | 2001 |
Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene.
The activation of antiviral drugs as a consequence of thymidine kinase expression has been shown in recent years to have potential as a treatment for malignant tumors. It was hypothesized that the property of the drugs that make them effective against viruses and proliferating cells, namely their ability to interfere with the integrity of the DNA, may be exploited to sensitize cells to radiation damage. The antiviral drug, BVdUrd, structurally a pyrimidine analogue, was found to enhance selectively the radiation cytotoxicity of human tumor cells transduced with the HSV-tk thymidine kinase gene. Human glioma cells from the U-251 lineage transduced with HSV-tk and exposed to 40 micrograms/ml of BVdUrd for 24 h prior to irradiation were more sensitive to radiation compared with control cells under the same conditions; the sensitization enhancement ratio was 1.9. The results suggest that the addition of radiation will improve the effectiveness of HSV-tk gene therapy for the treatment of brain tumors. Topics: Antiviral Agents; Bromodeoxyuridine; Cell Survival; Genetic Therapy; Glioma; Humans; Radiation Tolerance; Radiation-Sensitizing Agents; Simplexvirus; Thymidine Kinase; Transfection | 1994 |